Patents by Inventor Christine Huard

Christine Huard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-BMP9 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20240083991
    Abstract: Antibodies, and antigen-binding fragments thereof, that specifically bind to bone morphogenetic protein-9 (BMP9) are provided. Embodiments include uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Application
    Filed: May 31, 2023
    Publication date: March 14, 2024
    Applicants: Pfizer Inc., The Brigham and Women's Hospital, Inc., The General Hospital Corporation
    Inventors: Paul B. Yu, James Reasoner Apgar, Susan Adam Benard, Stephen Peter Berasi, Christine Huard, Oleg Victorovich Kovalenko, Lidia Mosyak, Xianchun Tang, Kathleen Elisabeth Tumelty, Luca Troncone, Ying Zhong
  • Interferon beta antibodies and uses thereof
    Patent number: 11858986
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.
    Type: Grant
    Filed: November 9, 2020
    Date of Patent: January 2, 2024
    Assignees: Pfizer Inc., The Brigham And Women's Hospital, Inc.
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • Anti-ROBO2 antibodies, compositions, methods and uses thereof
    Patent number: 11365253
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to ROBO2, as well as uses, and methods thereof.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: June 21, 2022
    Assignees: Pfizer Inc., Boston Medical Center Corporation
    Inventors: Stephen Berasi, Janet Elizabeth Buhlmann, Eric M. Bennett, Nathan Higginson-Scott, Huilan Gao, Zong Sean Juo, Stefano V. Gulla, Christine Huard, Sreekumar R. Kodangattil, Jian Li, Weining Lu, Xueping Fan, David J. Salant
  • INTERFERON BETA ANTIBODIES AND USES THEREOF
    Publication number: 20210163588
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.
    Type: Application
    Filed: November 9, 2020
    Publication date: June 3, 2021
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • Interferon beta antibodies and uses thereof
    Patent number: 10829553
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: November 10, 2020
    Assignees: PFIZER INC., THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • ANTI-ROBO2 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF
    Publication number: 20200157212
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to ROBO2, as well as uses, and methods thereof.
    Type: Application
    Filed: June 8, 2018
    Publication date: May 21, 2020
    Inventors: Stephen Berasi, Janet Elizabeth Buhlmann, Eric M. Bennett, Nathan Higginson-Scott, Huilan Gao, Zong Sean Juo, Stefano V. Gulla, Christine Huard, Sreekumar R. Kodangattil, Jian Li, Weining Lu, Xueping Fan, David J. Salant
  • INTERFERON BETA ANTIBODIES AND USES THEREOF
    Publication number: 20170313769
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes.
    Type: Application
    Filed: April 28, 2017
    Publication date: November 2, 2017
    Applicants: PFIZER INC., THE BRIGHAM AND WOMEN?S HOSPITAL, INC.
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • METHODS FOR PURIFYING ALUMINIUM IONS
    Publication number: 20170260062
    Abstract: There is provided a process for purifying aluminum ions comprising: reacting an aluminum-containing material with an acid so as to obtain a composition comprising aluminum ions; precipitating said aluminum ions in the form of AlCl3; optionally converting AlCl3 into Al(OH)3; and heating said AlCl3 or said Al(OH)3 under conditions effective for converting AlCl3 or Al(OH)3 into Al2O3 and optionally recovering gaseous HCl so-produced. Aluminum ions so purified are thus useful for preparing various types of alumina.
    Type: Application
    Filed: October 2, 2015
    Publication date: September 14, 2017
    Inventors: Richard BOUDREAULT, Joël FOURNIER, Hubert DUMONT, Jean-François SAMUEL, Jonathan BOUFFARD, Sophie LEPAGE, Ann-Christine HUARD, Claudia GRAVEL-ROULEAU, Marie-Maxime LABRECQUE-GILBERT
  • Methods for purifying aluminium ions
    Patent number: 9534274
    Abstract: There are provided processes for purifying aluminum ions. Such processes comprise precipitating the aluminum ions under the form of Al(OH)3 at a first pH range; converting Al(OH)3 into AlCl3 by reacting Al(OH)3 with HCl and precipitating said AlCl3; and heating the AlCl3 under conditions effective for converting AlCl3 into Al2O3 and optionally recovering gaseous HCl so-produced. The processes can also comprise converting alumina into aluminum.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: January 3, 2017
    Assignee: ORBITE TECHNOLOGIES INC.
    Inventors: Richard Boudreault, Joël Fournier, Hubert Dumont, Jean-François Samuel, Jonathan Bouffard, Sophie Lepage, Ann-Christine Huard, Claudia Gravel-Rouleau, Marie-Maxime Labrecque-Gilbert
  • METHODS FOR PURIFYING ALUMINIUM IONS
    Publication number: 20160273069
    Abstract: There are provided processes for purifying aluminum ions. Such processes comprise precipitating the aluminum ions under the form of Al(OH)3 at a first pH range; converting Al(OH)3 into AlCl3 by reacting Al(OH)3 with HCl and precipitating said AlCl3; and heating the AlCl3 under conditions effective for converting AlCl3 into Al2O3 and optionally recovering gaseous HCl so-produced. The processes can also comprise converting alumina into aluminum.
    Type: Application
    Filed: November 14, 2013
    Publication date: September 22, 2016
    Inventors: Richard BOUDREAULT, Joël FOURNIER, Hubert DUMONT, Jean-François SAMUEL, Jonathan BOUFFARD, Sophie LEPAGE, Ann-Christine HUARD, Claudia GRAVEL-ROULEAU, Marie-Maxime LABRECQUE-GILBERT
  • Modulators of gluconeogenesis
    Patent number: 7763441
    Abstract: The present invention provides methods of affecting gluconeogenesis by altering the levels or activity of DUSP4 and/or EGR1. Pharmaceutical compositions comprising or encoding modulators of gluconeogenesis are also disclosed.
    Type: Grant
    Filed: March 13, 2007
    Date of Patent: July 27, 2010
    Assignee: Wyeth
    Inventors: Stephen Berasi, Christine Huard, Dongmei Li, Heather Shih, Ying Sun, Janet Paulsen, Eugene L. Brown, Ruth Gimeno, Robert Martinez
  • METHODS AND COMPOSITIONS FOR MODULATING BMP-10 ACTIVITY
    Publication number: 20090017019
    Abstract: Methods and compositions for modulating cardiac, renal and vascular cell function and homeostasis using agonists and antagonists of BMP-10 are disclosed. In particular, methods for treating, preventing and/or diagnosing BMP-10-associated vascular, renal, fibrotic and cardiac conditions and/or disorders are disclosed. Screening methods for evaluating BMP-10 modulators, e.g., agonists and antagonists, are also disclosed.
    Type: Application
    Filed: May 30, 2008
    Publication date: January 15, 2009
    Applicant: Wyeth
    Inventors: Kathleen M. Shields, Debra D. Pittman, Jeffrey L. Feldman, Robert Martinez, Christine Huard
  • Modulators of gluconeogenesis
    Publication number: 20070270331
    Abstract: The present invention provides methods of affecting gluconeogenesis by altering the levels or activity of DUSP4 and/or EGR1. Pharmaceutical compositions comprising or encoding modulators of gluconeogenesis are also disclosed.
    Type: Application
    Filed: March 13, 2007
    Publication date: November 22, 2007
    Inventors: Stephen Berasi, Christine Huard, Dongmei Li, Heather Shih, Ying Sun, Janet Paulsen, Eugene Brown, Ruth Gimeno, Robert Martinez